Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ultrasound guided needle biopsy of axilla to evaluate nodal metastasis after preoperative systemic therapy in cohort of 106 breast cancers enriched with BRCA1/2 pathogenic variant carriers.
Līcīte B, Irmejs A, Maksimenko J, Loža P, Trofimovičs G, Miklaševičs E, Nazarovs J, Romanovska M, Deičmane J, Irmejs R, Purkalne G, Gardovskis J. Līcīte B, et al. Among authors: purkalne g. Hered Cancer Clin Pract. 2021 Jul 7;19(1):30. doi: 10.1186/s13053-021-00187-w. Hered Cancer Clin Pract. 2021. PMID: 34233740 Free PMC article.
Chromothripsis and progression-free survival in metastatic colorectal cancer.
Skuja E, Kalniete D, Nakazawa-Miklasevica M, Daneberga Z, Abolins A, Purkalne G, Miklasevics E. Skuja E, et al. Among authors: purkalne g. Mol Clin Oncol. 2017 Feb;6(2):182-186. doi: 10.3892/mco.2017.1123. Epub 2017 Jan 2. Mol Clin Oncol. 2017. PMID: 28357089 Free PMC article.
Deletions in metastatic colorectal cancer with chromothripsis.
Skuja E, Butane D, Nakazawa-Miklasevica M, Daneberga Z, Purkalne G, Miklasevics E. Skuja E, et al. Among authors: purkalne g. Exp Oncol. 2019 Dec;41(4):323-327. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-4.13841. Exp Oncol. 2019. PMID: 31868331
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
Markóczy Z, Sárosi V, Kudaba I, Gálffy G, Turay ÜY, Demirkazik A, Purkalne G, Somfay A, Pápai-Székely Z, Rásó E, Ostoros G. Markóczy Z, et al. Among authors: purkalne g. BMC Cancer. 2018 May 25;18(1):598. doi: 10.1186/s12885-018-4283-z. BMC Cancer. 2018. PMID: 29801465 Free PMC article. Clinical Trial.
Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Zemanova M, Pirker R, Petruzelka L, Zbozínkova Z, Jovanovic D, Rajer M, Bogos K, Purkalne G, Ceriman V, Chaudhary S, Richter I, Kufa J, Jakubikova L, Zemaitis M, Cernovska M, Koubkova L, Vilasova Z, Dieckmann K, Farkas A, Spasic J, Fröhlich K, Tiefenbacher A, Hollosi V, Kultan J, Kolarová I, Votruba J. Zemanova M, et al. Among authors: purkalne g. Radiol Oncol. 2020 May 28;54(2):209-220. doi: 10.2478/raon-2020-0026. Radiol Oncol. 2020. PMID: 32463394 Free PMC article.
36 results